S&P 500 4,966.81 (-0.88%)

DOW 37,990.25 (+0.57%)

QQQ 414.07 (-2.21%)

AAPL 164.99 (-1.23%)

MSFT 398.16 (-1.51%)

META 476.40 (-5.06%)

GOOGL 153.28 (-1.75%)

AMZN 173.54 (-3.17%)

TSLA 146.63 (-2.20%)

NVDA 760.13 (-10.23%)

AMD 146.23 (-5.71%)

NIO 3.79 (-5.25%)

BABA 68.94 (+0.09%)

T 16.49 (+0.98%)

F 12.10 (+0.33%)

MU 106.21 (-5.11%)

GE 148.09 (-3.17%)

CGC 7.97 (+1.79%)

DIS 112.24 (-0.17%)

AMC 3.13 (+7.19%)

PFE 25.96 (+2.24%)

PYPL 61.86 (-0.39%)

XOM 119.93 (+1.19%)

S&P 500 4,966.81 (-0.88%)

DOW 37,990.25 (+0.57%)

QQQ 414.07 (-2.21%)

AAPL 164.99 (-1.23%)

MSFT 398.16 (-1.51%)

META 476.40 (-5.06%)

GOOGL 153.28 (-1.75%)

AMZN 173.54 (-3.17%)

TSLA 146.63 (-2.20%)

NVDA 760.13 (-10.23%)

AMD 146.23 (-5.71%)

NIO 3.79 (-5.25%)

BABA 68.94 (+0.09%)

T 16.49 (+0.98%)

F 12.10 (+0.33%)

MU 106.21 (-5.11%)

GE 148.09 (-3.17%)

CGC 7.97 (+1.79%)

DIS 112.24 (-0.17%)

AMC 3.13 (+7.19%)

PFE 25.96 (+2.24%)

PYPL 61.86 (-0.39%)

XOM 119.93 (+1.19%)

S&P 500 4,966.81 (-0.88%)

DOW 37,990.25 (+0.57%)

QQQ 414.07 (-2.21%)

AAPL 164.99 (-1.23%)

MSFT 398.16 (-1.51%)

META 476.40 (-5.06%)

GOOGL 153.28 (-1.75%)

AMZN 173.54 (-3.17%)

TSLA 146.63 (-2.20%)

NVDA 760.13 (-10.23%)

AMD 146.23 (-5.71%)

NIO 3.79 (-5.25%)

BABA 68.94 (+0.09%)

T 16.49 (+0.98%)

F 12.10 (+0.33%)

MU 106.21 (-5.11%)

GE 148.09 (-3.17%)

CGC 7.97 (+1.79%)

DIS 112.24 (-0.17%)

AMC 3.13 (+7.19%)

PFE 25.96 (+2.24%)

PYPL 61.86 (-0.39%)

XOM 119.93 (+1.19%)

S&P 500 4,966.81 (-0.88%)

DOW 37,990.25 (+0.57%)

QQQ 414.07 (-2.21%)

AAPL 164.99 (-1.23%)

MSFT 398.16 (-1.51%)

META 476.40 (-5.06%)

GOOGL 153.28 (-1.75%)

AMZN 173.54 (-3.17%)

TSLA 146.63 (-2.20%)

NVDA 760.13 (-10.23%)

AMD 146.23 (-5.71%)

NIO 3.79 (-5.25%)

BABA 68.94 (+0.09%)

T 16.49 (+0.98%)

F 12.10 (+0.33%)

MU 106.21 (-5.11%)

GE 148.09 (-3.17%)

CGC 7.97 (+1.79%)

DIS 112.24 (-0.17%)

AMC 3.13 (+7.19%)

PFE 25.96 (+2.24%)

PYPL 61.86 (-0.39%)

XOM 119.93 (+1.19%)

Free Trial

Compare Stocks

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable

ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	Abattis Bioceuticals Corp ATTBF morningstar.com - November 11 at 8:24 AM
	Illumina Aktie finanzen100.de - June 28 at 8:57 PM
	How a Jungle Prison Became a Famous Spaceport smithsonianmag.com - June 24 at 12:03 AM
	Isotretinoin Price of 93 Brands medindia.net - May 9 at 12:56 PM
	Ivermectin Price of 102 Brands medindia.net - April 20 at 12:36 PM
	Abattis Bioceuticals Corp ATTBF Sustainability morningstar.com - September 9 at 10:20 PM
	When Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay? benzinga.com - March 27 at 6:36 PM
	Cannabis Payments Co Launches Women In Finance & Technology Scholarship benzinga.com - March 26 at 8:52 PM
	Charlotte's Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5M benzinga.com - March 25 at 11:58 PM
	Federal Marijuana Cases Drop Again In 2021 As More States Legalize benzinga.com - March 20 at 10:08 PM
	Schwazze Common Shares Will Trade On NEO Exchange Under Symbol 'SHWZ' In Late March benzinga.com - March 20 at 10:08 PM
	MDXclusive Launches Lab-Tested Topical And Sublingual CBD Products benzinga.com - March 9 at 9:22 PM
	The Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic Effects benzinga.com - March 6 at 7:27 PM
	Most D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New Bill benzinga.com - March 5 at 10:25 PM
	BDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026 benzinga.com - March 3 at 8:58 PM
	Trulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 Acquisitions benzinga.com - January 26 at 12:56 AM
	Latest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And New benzinga.com - December 22 at 6:09 PM
	Abattis Bioceuticals Dividend Per Share (TTM) ycharts.com - December 18 at 12:59 AM
	Abattis Bioceuticals EPS Diluted (5 Year Growth) ycharts.com - December 18 at 12:59 AM
	Micah Tapman Of BDSA Lays Out Cannabis Data In The Northeast benzinga.com - October 18 at 7:08 PM
	Apple's Cannabis iPhone App Is Benefiting Businesses And Consumers, Where's Google Play Store? benzinga.com - September 3 at 9:10 PM
	Panama Is Close To Legalizing Medicinal Cannabis benzinga.com - August 31 at 6:25 PM
	EXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? It's Complicated benzinga.com - August 18 at 3:50 AM

New MarketBeat Followers Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Price Performance

MarketRank™

Analyst Ratings

Sales & Book Value

Profitability & Earnings

Dividends

Ownership

Institutional Ownership

Insider Ownership

Miscellaneous

ATTBF, ABCN, ABZA, and AHZ Headlines

New MarketBeat Followers Over Time

Company Descriptions

VIVO Cannabis

Abattis Bioceuticals

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info